Hostname: page-component-7b7567c8c-2n9c9 Total loading time: 0 Render date: 2026-11-19T03:27:26.170Z Has data issue: false hasContentIssue false

Counterfeit medicines and the unregulated market for drugs

Published online by Cambridge University Press:  02 January 2018

Hamid Ghodse*
Affiliation:
International Psychiatry
Rights & Permissions [Opens in a new window]

Extract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the 'Save PDF' action button.

The unregulated market for medicines has evolved in different ways and exists in different forms in different parts of the world. Given this wide variation, the phrase ‘unregulated market for drugs’ is commonly used in a generic sense and encompasses the sale of medicines that have been licitly manufactured but diverted from legitimate sales routes as well as the illicit manufacture and sale of (counterfeit) pharmaceuticals. Also within this unregulated environment, prescription-only drugs are sold (illegally) without prescription.

Information

Type
Editorial
Creative Commons
Creative Common License - CCCreative Common License - BYCreative Common License - NCCreative Common License - ND
This is an Open Access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits noncommercial re-use, distribution, and reproduction in any medium, provided the original work is unaltered and is properly cited. The written permission of Cambridge University Press must be obtained for commercial re-use or in order to create a derivative work.
Copyright
Copyright © Royal College of Psychiatrists 2008
Submit a response

eLetters

No eLetters have been published for this article.